News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
235,861 Results
Type
Article (5127)
Company Profile (23)
Press Release (230711)
Multimedia
Podcasts (3)
Webinars (4)
Section
Business (82273)
Career Advice (464)
Deals (15061)
Drug Delivery (9)
Drug Development (19091)
Employer Resources (30)
FDA (3686)
Job Trends (3922)
News (120239)
Policy (7516)
Tag
2027 BioCapital Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (303)
Accelerated approval (10)
ADA (11)
Adcomms (4)
Allergies (26)
Alliances (14813)
ALS (54)
Alzheimer's disease (333)
Antibody-drug conjugate (ADC) (79)
Approvals (3842)
Artificial intelligence (142)
ASCO (48)
Autoimmune disease (66)
Automation (14)
Bankruptcy (97)
Best Places to Work (2866)
BIO (19)
Biosimilars (40)
Biotechnology (22)
Bladder cancer (44)
Brain cancer (16)
Breast cancer (131)
Cancer (1173)
Cardiovascular disease (87)
Career advice (397)
Career pathing (4)
CAR-T (79)
CDC (3)
Celiac Disease (1)
Cell therapy (207)
Cervical cancer (8)
Clinical research (17110)
Collaboration (484)
Compensation (477)
Complete response letters (13)
COVID-19 (316)
CRISPR (19)
C-suite (497)
Cystic fibrosis (28)
Data (1870)
Denatured (2)
Depression (26)
Dermatology (24)
Diabetes (115)
Diagnostics (2198)
Digital health (14)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (52)
Drug pricing (15)
Drug shortages (2)
Duchenne muscular dystrophy (52)
Earnings (43898)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39950)
Executive appointments (489)
FDA (4583)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (8)
Frontotemporal dementia (14)
Funding (421)
Gene editing (32)
Generative AI (7)
Gene therapy (125)
GLP-1 (162)
Government (440)
Guidances (206)
Healthcare (5126)
Hematology (51)
HIV (15)
Huntington's disease (8)
IgA nephropathy (18)
Immunology and inflammation (47)
Immuno-oncology (16)
Indications (38)
Infectious disease (355)
Inflammatory bowel disease (39)
Inflation Reduction Act (3)
Influenza (11)
Intellectual property (39)
Interviews (53)
IPO (7890)
IRA (3)
Job creations (1123)
Job search strategy (361)
JPM (4)
Kidney cancer (14)
Labor market (14)
Layoffs (112)
Leadership (7)
Legal (2339)
Liver cancer (22)
Longevity (4)
Lung cancer (132)
Lymphoma (92)
Machine learning (10)
Management (10)
Manufacturing (212)
MASH (62)
Medical device (3952)
Medtech (3992)
Mergers & acquisitions (7651)
Metabolic disorders (297)
mRNA (14)
Multiple sclerosis (24)
NASH (6)
Neurodegenerative disease (79)
Neuropsychiatric disorders (13)
Neuroscience (667)
NextGen: Class of 2026 (1675)
Non-profit (735)
Now hiring (7)
Obesity (117)
Opinion (34)
Ovarian cancer (44)
Pain (32)
Pancreatic cancer (64)
Parkinson's disease (75)
Partnered (6)
Patents (64)
Patient recruitment (144)
Peanut (6)
People (25622)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (5120)
Phase 2 (7448)
Phase 3 (5931)
Pipeline (3329)
Policy (25)
Postmarket research (625)
Preclinical (1982)
Press Release (66)
Prostate cancer (74)
Psychedelics (3)
Radiopharmaceuticals (131)
Rare diseases (240)
Real estate (1890)
Recruiting (8)
Regulatory (5756)
Reports (18)
Research institute (309)
Resumes & cover letters (69)
Rett syndrome (28)
RNA editing (2)
RSV (2)
Schizophrenia (60)
Series A (73)
Series B (70)
Sickle cell disease (18)
Special edition (1)
Spinal muscular atrophy (37)
Sponsored (5)
Startups (1019)
Stomach cancer (1)
Supply chain (19)
Tariffs (7)
The Weekly (1)
Vaccines (98)
Venture capital (16)
Weight loss (42)
Women's health (10)
Worklife (1)
Date
Today (27)
Last 7 days (105)
Last 30 days (663)
Last 365 days (8922)
2026 (4579)
2025 (9036)
2024 (11029)
2023 (13195)
2022 (18665)
2021 (19685)
2020 (18246)
2019 (13209)
2018 (10211)
2017 (10002)
2016 (9161)
2015 (12120)
2014 (9593)
2013 (7713)
2012 (8331)
2011 (8796)
2010 (8636)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (82)
Arkansas (2)
Asia (11953)
Australia (1728)
California (4377)
Canada (1344)
China (230)
Colorado (174)
Connecticut (215)
Delaware (85)
Europe (26124)
Florida (672)
Georgia (90)
Idaho (24)
Illinois (210)
India (26)
Indiana (140)
Iowa (9)
Japan (236)
Kansas (42)
Kentucky (19)
Louisiana (11)
Maine (57)
Maryland (419)
Massachusetts (3575)
Michigan (109)
Minnesota (231)
Mississippi (1)
Missouri (40)
Montana (18)
Nebraska (12)
Nevada (55)
New Hampshire (16)
New Jersey (1257)
New Mexico (5)
New York (992)
North Carolina (580)
North Dakota (5)
Northern California (2336)
Ohio (143)
Oklahoma (5)
Oregon (7)
Pennsylvania (756)
Puerto Rico (3)
Rhode Island (20)
South America (279)
South Carolina (19)
Southern California (1658)
Tennessee (76)
Texas (630)
United States (15299)
Utah (145)
Vermont (1)
Virginia (110)
Washington D.C. (17)
Washington State (382)
West Virginia (2)
Wisconsin (71)
Wyoming (1)
235,861 Results for "neurologica corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
NeuroLogica Corp Receives Innovative Technology Designation from Vizient for OmniTom Elite PCD
NeuroLogica Corp. announces its OmniTom Elite PCD has received an Innovative Technology designation from Vizient, Inc., the largest provider-driven healthcare performance improvement company in the country.
January 11, 2024
·
3 min read
Press Releases
Britannia Life Sciences Provides Corporate Update
Corporate Treasury Positioned with Cash and Liquid Equity Holdings to Seed, Incubate and Accelerate New and Existing Operations
May 21, 2026
·
4 min read
FDA
NeuroLogica Announces FDA 510(k) Clearance of BodyTom® 64
NeuroLogica Announces FDA 510(k) Clearance of BodyTom ® 64.
November 28, 2022
·
3 min read
Genetown
NeuroLogica Installs Next-Generation SmartMSU™ with OmniTom® Elite in the Asia-Pacific Region
NeuroLogica Corp., a subsidiary of Samsung Electronics Co. Ltd., announced the first installation of its SmartMSU™ with OmniTom® Elite – a specialized ambulance that is equipped with a small computed tomography (CT) scanner for head imaging – in the Asia-Pacific region.
December 15, 2022
·
4 min read
Genetown
NeuroLogica Announces a Research Partnership with the University of Dundee Using State-of-the-Art Photon Counting Detector Technology
NeuroLogica Corp., a subsidiary of Samsung Electronics Co. Ltd., announced a partnership with The University of Dundee in Scotland, United Kingdom, to collaborate on research using the OmniTom® Elite with Photon Counting Detector computed tomography imaging technology.
January 4, 2023
·
3 min read
Genetown
NeuroLogica Receives CE Marking for all Elite Mobile Computed Tomography Systems
NeuroLogica Corp., a subsidiary of Samsung Electronics Co. Ltd., announced today that its state-of-the-art Elite Mobile Computed Tomography (CT) systems have received the European Union (EU) CE marking via compliance with the new EU Medical Device Regulation (MDR 2017/745).
October 12, 2022
·
3 min read
Press Releases
CEL-SCI Corporation Announces Pricing of Offering
June 15, 2026
·
3 min read
Press Releases
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 14, 2026
·
14 min read
Press Releases
enVVeno Medical to Present in the Webull Corporate Connect Webinar Series
June 22, 2026
·
2 min read
Press Releases
Alnylam Issues 2025 Corporate Responsibility Report
May 19, 2026
·
4 min read
1 of 23,587
Next
